- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The prognostic and therapeutic potential of HO-1 in leukemia and MDS ; volume:21 ; number:1 ; day:13 ; month:3 ; year:2023 ; pages:1-21 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (13.3.2023), 1-21, 12.2023
- Creator
-
Sadeghi, Mohammad
Fathi, Mehrdad
Gholizadeh Navashenaq, Jamshid
Mohammadi, Hamed
Yousefi, Mehdi
Hojjat-Farsangi, Mohammad
Namdar, Afshin
Movasaghpour Akbari, Ali Akbar
Jadidi-Niaragh, Farhad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01074-8
- URN
-
urn:nbn:de:101:1-2408120906080.777516972533
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sadeghi, Mohammad
- Fathi, Mehrdad
- Gholizadeh Navashenaq, Jamshid
- Mohammadi, Hamed
- Yousefi, Mehdi
- Hojjat-Farsangi, Mohammad
- Namdar, Afshin
- Movasaghpour Akbari, Ali Akbar
- Jadidi-Niaragh, Farhad
- SpringerLink (Online service)
Other Objects (12)
Cysteine Cathepsins and Their Prognostic and Therapeutic Relevance in Leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
GATA2 deficiency and MDS/AML : : experimental strategies for disease modelling and future therapeutic prospects
MDS
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Cysteine Cathepsins and Their Prognostic and Therapeutic Relevance in Leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
GATA2 deficiency and MDS/AML : : experimental strategies for disease modelling and future therapeutic prospects
MDS
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
Cysteine Cathepsins and Their Prognostic and Therapeutic Relevance in Leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
GATA2 deficiency and MDS/AML : : experimental strategies for disease modelling and future therapeutic prospects
MDS
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications